PE-Labeled Siglec-2/CD22 Fc&Avi Tag: The "Triple Signal Amplifier" for B Cell Research

PE-Labeled Siglec-2/CD22 Fc&Avi Tag is a highly integrated advanced recombinant protein probe, representing the evolutionary direction of engineered protein tools. Building upon the basic version of the CD22 extracellular domain probe, it achieves modular integration of three major functions—signal detection, functional regulation, and biotinylation-derived applications—through the fusion of an Fc tag and AviTag, along with phycoerythrin labeling. The core design philosophy of this molecule transcends the conventional "fluorescent tag" concept, positioning it as a "platform-type" research tool that combines high-sensitivity detection, multifunctional auxiliary applications, and limitless customizable expansion. It offers unprecedented flexibility and depth for exploring B cell biology.

This protein is a multifunctional composite probe constructed through a combination of genetic engineering and chemical/enzymatic modifications. Its structure comprises four synergistic precision modules:

CD22/Siglec-2 Extracellular Domain Binding Module: Serving as the core of the probe, it consists of the extracellular domain of human CD22 protein, responsible for specifically recognizing and binding α2,6-sialylated glycan ligands, ensuring highly specific targeting of B cells and their microenvironment.

Fc Tag (typically IgG1 Fc): Fused to the C- or N-terminus of the CD22 extracellular domain, its functionality extends far beyond mere stabilization:

Universal Secondary Detection Platform: Provides a universal binding site for any species-derived secondary anti-Fc antibodies conjugated with arbitrary fluorescent dyes or enzyme labels, enabling signal amplification and multicolor multiplexing.

Functional Crosslinking Induction: Enables probe crosslinking on B cell surfaces via anti-Fc antibodies, mimicking ligand clustering to directly study CD22 crosslinking-induced activation of downstream inhibitory signals or endocytosis processes.

AviTag: A 15-amino-acid short peptide tag that can be specifically and efficiently biotinylated by biotin ligase in vitro or in vivo.

Flexible Conjugation Portal: After biotinylation, the probe can be easily and directionally conjugated to any streptavidin/avidin-pre-labeled carrier (e.g., fluorescent dyes, quantum dots, magnetic beads, enzymes, or drug molecules) via ultra-high-affinity binding, achieving "on-demand customization" of functionality.

Direct Phycoerythrin Labeling: Post-purification, the protein is covalently labeled with R-phycoerythrin, a multimeric fluorescent protein composed of multiple chromophores.

Ultra-High Brightness: PE is one of the brightest fluorescent dyes available for flow cytometry, with fluorescence intensity far exceeding that of monomeric small-molecule dyes (e.g., FITC, Alexa Fluor 647). It generates exceptionally strong signals, making it ideal for detecting low-abundance expression or studying weak signals.

Design Logic Overview: This probe is a "trinity" scientific platform. PE serves as a powerful "main cannon," providing direct, potent fluorescent signals without secondary antibodies; the Fc tag acts as a "multifunctional interface," allowing connection to other tools for signal amplification or functional manipulation; and the AviTag is the "future upgrade interface," reserving a standardized port for infinite functional expansions (e.g., fluorescence swapping or drug conjugation).

The power of this probe lies in its support for multiple operational modes, adapting to diverse needs ranging from basic detection to complex functional experiments.

PE-labeled direct fluorescence imaging: Pre-conjugated with PE, it can be directly used for flow cytometry or fluorescence microscopy to one-step label CD22 ligand-binding sites. PE's exceptional brightness enables clear distinction of weakly positive populations from background noise in multicolor analyses or provides high-contrast signals in imaging.

Anti-Fc secondary antibody cascade amplification: When detecting extremely low-expression targets or requiring ultimate sensitivity, this probe (without PE or even with PE that can be overridden) can first bind cells, followed by detection using anti-Fc secondary antibodies conjugated with brighter dyes (e.g., PE-Cy7, Brilliant Violet 421) or multimeric fluorescent systems, achieving exponential signal amplification.

Unlocking arbitrary fluorescence channels: By selecting anti-Fc secondary antibodies with different fluorescent labels, the probe's detection signal can be "assigned" to any available flow cytometry channel, resolving conflicts with other critical PE-channel reagents and greatly enhancing flexibility in multicolor experimental design.

Inducing receptor crosslinking and signal studies: Utilizing its Fc tag, after probe-cell binding, anti-Fc F(ab')₂ fragment antibodies can be added. This crosslinking mimics physiological ligand clustering, directly activating CD22-mediated downstream inhibitory signaling pathways (e.g., SHP-1 recruitment) or triggering receptor endocytosis and degradation for functional studies.

Specific blockade and competition experiments: As a high-concentration soluble ligand, it can efficiently competitively block endogenous CD22 interactions with membrane ligands, verifying CD22's necessity in specific B cell functions.

On-demand customization: Through AviTag biotinylation, this probe can be easily converted into a PE-labeled streptavidin-capture probe or linked to biotinylated molecules (e.g., different fluorescent dyes, therapeutic payloads) to create customized tools for specific experimental needs (e.g., live imaging, targeted delivery).

This multifunctional probe platform demonstrates unique value across all levels of B cell-related research.

Identification of rare B cell subsets: Such as autoreactive B cells, regulatory B cells (Breg), and age-associated B cells, which may exhibit unique CD22 expression levels or sialylation states. PE's high brightness ensures their precise identification and sorting.

Fine analysis of development and differentiation: Combined with other markers, it enables high-resolution tracking of dynamic changes in CD22 ligand environments throughout B cell differentiation from progenitors to plasma cells.

Deep immunophenotyping of B cell lymphomas: Precisely quantifies functional ligand-binding sites (not just protein abundance) on CD22 in different lymphoma subtypes (e.g., CLL, FL, DLBCL), providing more accurate efficacy predictions for antibody-drug conjugates.

Monitoring therapeutic antibody target occupancy: When using anti-CD22 antibody drugs (e.g., Epratuzumab), this probe can detect remaining unoccupied CD22 binding sites, directly assessing in vivo drug coverage.

Quantifying inhibitory signal states in disease-associated B cells: In SLE, RA, and other diseases, it investigates whether abnormal sialylation or altered CD22 ligands cause inhibitory receptor "blindness" or dysfunction in patient B cells, serving as an ideal quantitative tool.

In vitro functional validation of bispecific antibodies/ADCs: Serves as a standardized target-binding module to validate the affinity, specificity, and competitiveness of novel anti-CD22 drugs.

CAR-T cell functional assessment: Tests the recognition and killing efficiency of anti-CD22 CAR-T cells against target cells expressing varying levels of CD22 ligands.

As a platform-type tool, its future development will focus on "programmability" and "intelligence," integrating into the full chain of life science research.

"Plug-and-play" modular toolkit: Future commercial kits may offer biotinylated "core modules" (CD22-Fc-Avi) paired with standardized streptavidin-"functional modules" (e.g., different fluorophores, isotopes, drugs, enzymes), enabling true DIY probe assembly based on experimental needs.

Deep applications in live and dynamic imaging: Leveraging AviTag to conjugate probes with NIR-II fluorescent dyes or bioluminescent molecules for small-animal live imaging, enabling real-time, non-invasive tracking of B cell distribution and dynamics in lymphoid organs, tumors, or autoimmune lesions.

Integration with single-cell multi-omics: Combining CITE-seq technology, DNA-barcoded anti-Fc secondary antibodies can identify this probe, enabling simultaneous acquisition of B cell surface CD22 ligand-binding profiles, transcriptomes, and chromatin accessibility at single-cell resolution.

Spatial proteomics in situ labeling: Optimized versions for multiplex immunofluorescence, combined with CODEX or IMC technologies, will enable ultrahigh-plex imaging of CD22 ligand-binding microenvironments in tissues, deciphering spatial functional niches in germinal center reactions or tumor immune microenvironments.

Closed-loop theranostics development platform: AviTag's flexibility allows simultaneous conjugation of diagnostic fluorescent molecules and therapeutic radionuclides or toxins. The same probe can first preoperatively image CD22-positive lesions, then switch "warheads" for intraoperative navigation or targeted therapy, achieving integrated diagnosis and treatment.

PE-Labeled Siglec-2/CD22 Fc&Avi Tag is not merely an incremental upgrade over previous fluorescent probes; it represents a paradigm shift from "single-function reagents" to "modular, extensible platforms." By integrating the brightest signals, most versatile interfaces, and limitless expandability, it empowers researchers not only to "see" the CD22 world on B cell surfaces but also to "manipulate" and "reconstruct" it. From unveiling nanoscale details of immune inhibitory signals to enabling precision development of next-generation cell therapies, this "triple-function signal amplifier" has become a powerful hub connecting B cell basic biology and translational innovation. As synthetic biology and nanotechnology further converge, such platform-based "smart bio-probes" will serve as core engines in dynamically dissecting life processes and driving the precision medicine revolution.